monoclonal antibodies J591, Small molecule inhibitors such as glutamate-urea-lysine (Glu-urea-Lys), PSMA-I&T, PSMAI&S, and PSMA-617 have been widely used in targeted therapy of PCa (62). This evidence concerns the gene FOLH1 and posterior cortical atrophy.